Regenerative medicine for canine joints is evolving fast. Here's an honest look at where PRP and stem cell therapy stand today.
Platelet-rich plasma (PRP) and stem cell therapy have moved from experimental to clinically available in canine medicine over the past decade. The marketing around them is enthusiastic. The clinical evidence is more measured but increasingly supportive.
Trust mechanism. Verify dosing. Be patient. Here's the honest version of what these therapies are, what they can do, and how to evaluate whether your dog is a candidate.
What PRP actually is
Blood is drawn from the dog, processed in a centrifuge to concentrate the platelets and growth factors, and then injected directly into the affected joint. The growth factors and signaling molecules in concentrated platelets are thought to promote healing of cartilage, ligaments, and surrounding tissues.
The procedure is typically done under sedation, takes 30 to 60 minutes, and has minimal recovery time. Many dogs are walking normally the next day.
The evidence for PRP
Multiple veterinary studies show measurable improvements in lameness, joint function, and owner-rated quality of life in dogs with osteoarthritis treated with intra-articular PRP. Effect sizes are moderate, comparable to other regenerative interventions.
Effects typically last several months to a year. Repeat injections are common in chronic management protocols. The treatment is relatively low-risk because the material is the dog's own blood — no foreign substance.
What stem cell therapy involves
Adipose-derived stem cells are harvested from the dog's own fat tissue (usually a small surgical procedure under anesthesia), processed to isolate the stem cells, and either injected back into the affected joint or banked for future use.
Some protocols use allogeneic stem cells (from a donor dog) to avoid the harvest procedure. Others use cultured stem cells expanded in a laboratory before injection.
The evidence for stem cells
Veterinary studies show improvements similar to or greater than PRP in dogs with osteoarthritis, with effects often lasting 6 to 12 months from a single injection. The data is supportive but the studies are smaller than the PRP literature.
Animal studies in laboratory settings show stem cells can differentiate into chondrocytes and contribute to cartilage repair. Clinical evidence in real-world dogs supports moderate symptomatic improvement, though the regenerative claims sometimes outrun the cartilage-imaging evidence.
Cost
PRP injections typically cost $500 to $1,500 per joint per session. Stem cell therapy ranges from $1,500 to $5,000 depending on protocol and provider.
These are not small numbers. The cost-benefit conversation depends on the dog's overall management, life expectancy, and the alternatives available. Many owners use these therapies to reduce reliance on chronic medications or to delay surgery.
Who's a candidate
Best evidence is for moderate to severe osteoarthritis in dogs whose joints aren't responding fully to conventional management. Acute injuries (cruciate tears, fractures) are less commonly treated with these therapies as primary intervention.
Dogs with active infections, certain cancers, or coagulation disorders aren't candidates. Older dogs and dogs with multiple co-morbidities require more careful workup.
Where to get it
Veterinary specialty hospitals, surgical practices, and an increasing number of progressive general practices. Look for practitioners who use validated processing systems, follow established protocols, and can speak honestly about expected outcomes.
Avoid clinics that promise dramatic transformations or claim to 'cure' arthritis. The realistic outcome is measurable improvement, not regeneration of a young joint.
Where these therapies fit
PRP and stem cells are advanced adjunct interventions. They're not first-line therapy and they don't replace foundational management — weight, exercise, supportive nutrition, NSAIDs when appropriate.
For owners who've optimized the basics and are looking for the next level of intervention, regenerative therapies are increasingly part of the conversation. The field is evolving; what's available in five years will likely be more refined than what's available now.
Common questions about regenerative therapy
Will it cure my dog's arthritis? No. Realistic outcomes are measurable improvement in symptoms and function, often lasting 6 to 12 months. Repeat treatments are common in chronic management.
Is one treatment enough? For some dogs and earlier disease, yes. For more severe or progressive cases, a series or repeat treatments are often part of the plan.
Will insurance cover it? Some pet insurance plans cover regenerative therapies. Check your policy before committing — costs are meaningful.
Are there risks? Generally low — the materials used are typically the dog's own (autologous) tissue. Procedure-related risks are similar to any sedated joint injection.
What to track at home
Mobility metrics monthly post-procedure. Pain medication needs. Activity tolerance compared to pre-procedure baseline.
Subjective quality-of-life rating — willingness to engage in favorite activities, sleep quality, overall demeanor.
Where our formulas fit
Regenerative therapies work best alongside, not instead of, the foundational stack — weight management, exercise, and daily joint-supportive nutrition. The straightforward case for Joint Power: one input, one ingredient, several mechanisms. Dogs whose joint disease is not fully managed by conventional means are the typical candidates — the mussel naturally provides glucosamine, chondroitin sulfate, EPA, DHA, and ETA in a single freeze-dried serving.
Related reading
The bottom line
Skepticism is healthy in the wellness aisle. Take it everywhere. Most products don't survive a careful read of the actives panel. The few that do are the ones worth your money and your dog's time.